DJIA 16,533.47 182.09 1.11%
NASDAQ 4,792.22 42.24 0.89%
S&P 500 1,972.21 23.35 1.20%
market minute promo

DexCom, Inc. (NASDAQ: DXCM)

89.20 -0.17 (-0.19%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

DXCM $89.20 -0.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.89
Previous Close $89.37
Daily Range $88.89 - $90.64
52-Week Range $38.77 - $98.85
Market Cap $7.1B
P/E Ratio -343.73
Dividend (Yield) $0.00 (0.0%)
Volume 137,960
Average Daily Volume 1,039,890
Current FY EPS -$0.11




Healthcare IT

DexCom, Inc. (DXCM) Description

A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes. Website:

News & Commentary

This Top Diabetes Stock Just Extended Its Lead

Diabetes all-star Dexcom managed to win an earlier-than-expected FDA approval for its new G5 Mobile system, and the company looks poised for more stellar growth. Daily Round Up 9/1/15: Diamondback Energy, Gap, NuStar, Opko Health

DexCom Wins FDA Approval for G5 CGM System; Stock Up

3 Little-Known Medtech Stocks Investors Ought To Consider

Masimo Corp, Abiomed, and DexCom may be worthy of long haul portfolios.

Panic-Proofing the Small Investor

Insider Trading Alert - DXCM, ADC And JNPR Traded By Insiders

FDA Approves Dexcom G5® Mobile Continuous Glucose Monitoring System

Keeping A Small Nest Egg From Cracking

Google to Spin Off Life Sciences into an Alphabet Subsidiary

How Google Wants to Help Change Diabetes Forever

See More DXCM News...

DXCM's Top Competitors

DXCM $89.20 (-0.19%)
Current stock: DXCM
$0.00 (0.00%)
Current stock:
MDT $71.82 (0.38%)
Current stock: MDT
COV $0.00 (0.00%)
Current stock: COV